Jason Myers, PhD, CEO of the New Zealand AIDS Foundation, addresses how New Zealand promptly adjusted its delivery of services for people living with HIV and AIDS in New Zealand, with examples including HIV self-test kits, online counseling, and provision of mental health care assistance.
Jason Myers, PhD, CEO of the New Zealand AIDS Foundation, addresses how New Zealand promptly adjusted its delivery of services for people living with HIV and AIDS, with examples including HIV self-test kits, online counseling, and provision of mental health care assistance.
Transcript
How did the COVID-19 pandemic affect services in New Zealand for people living with HIV/AIDS?
In terms of impact on service access for people living with HIV, I think it has been limited. The impact has been limited, I should be clear. Organizations like ours, for example, have pivoted very quickly to ensure that the support services that we would ordinarily offer in person for counseling, for example, are available online. The HIV and STI [sexually transmitted infection] testing services we would provide, we are now sending out in the form of HIV self-test kits and providing the wraparound support required for people doing one of those tests in their homes.
In terms of specialist care for people living with HIV, nearly everybody living with HIV in New Zealand will be linked to care and will have very sophisticated and developed relationships with both a specialist HIV physician and a specialist HIV nurse. So, through these times contact is often made with people living with HIV to check not only on things like, do you have enough medication to get you through, do we need to get that sorted, but also other things—just like the impact of COVID-19 lockdowns on mental health and how the system might be able to support.
So, I haven't heard any stories of imperfect or inadequate care for people living with HIV resulting from the strict public health measures that have come about.
Reduced Rehospitalizations and Potential Cost Savings With Orca-T for Acute Leukemia, MDS
April 11th 2025Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More